Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Expression of IL-32 modulates NF-kappa B and p38 MAP kinase pathways in human esophageal cancer
Nasser Ghaly Yousif et al.
CYTOKINE (2013)
Impact of Interleukin-10 Gene Polymorphisms on Survival in Patients with Colorectal Cancer
Wen-Chien Ting et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-γ
Savvas Petanidis et al.
PLOS ONE (2013)
Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals
H-M Yun et al.
CELL DEATH & DISEASE (2013)
Meeting the biologic challenge of colorectal metastases
Harold J. Wanebo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis
Yaron Carmi et al.
JOURNAL OF IMMUNOLOGY (2011)
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals
J. H. Oh et al.
ONCOGENE (2011)
Unravelling the complexity of metastasis - molecular understanding and targeted therapies
Nilay Sethi et al.
NATURE REVIEWS CANCER (2011)
IL-32γ and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2
Bas Heinhuis et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype
Carlo Sorrentino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
Interleukin-32 Expression in the Pancreas
Atsushi Nishida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease
Fiorella Calabrese et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32)
P. Conti et al.
AUTOIMMUNITY REVIEWS (2007)
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
A Ben-Baruch
SEMINARS IN CANCER BIOLOGY (2006)
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim et al.
CANCER RESEARCH (2006)
Benefit of operative mortality reduction on colorectal cancer survival
E Mitry et al.
BRITISH JOURNAL OF SURGERY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
